New GenVec CEO eliminates jobs

GenVec's new CEO, Cynthia Collins, will restructure the company, eliminating about a third of its workforce. Collins, who joined GenVec in the spring, announced she will slash 23 jobs throughout the organization. She said cuts are necessary "to ensure that our costs are more closely aligned with our resources and business strategy." Release | FierceBiotech story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.